These compounds may interact with:
SUMO-activating enzyme subunit 1
Potentially involved in: multiple sclerosis; adrenocortical carcinoma; astrocytic glioma; atypical teratoid/rhabdoid tumor; lung cancer; medulloblastoma; osteosarcoma; ovarian cancer; rheumatoid arthritis
Disease data sourced from Pharos.